Clinical Research Studies of Atimociclib in HR+/HER2- and/or HER2+ Breast Cancer supports investigators studying atimociclib combinations to generate clinical evidence for breast cancer treatment.
Implementation of an Integrated Precision Care Pathway Program for Metastatic Prostate Cancer supports healthcare teams' quality improvement work to improve testing and coordinated care in Mainland China.
Clinical Cancer Research supports investigators conducting patient-centered cancer trials and early-detection studies to improve treatment options, enable earlier intervention, and enhance quality of life.
Career Development Award in HER2 supports pathologists, emphasizing early-career researchers, to optimize and validate HER2 testing in solid tumors beyond breast and gastric cancer to improve patient selection.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
Investigator Sponsored Trials and Collaborative Studies support external researchers and Genmab’s study partners in clinical and preclinical research aimed at addressing unmet medical needs.